Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call
Prenetics (NASDAQ: PRE) will release third quarter 2025 financial results for the period ended September 30, 2025 before market open on Monday, November 10, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Prenetics (NASDAQ: PRE) will release third quarter 2025 financial results for the period ended September 30, 2025 before market open on Monday, November 10, 2025. The company will hold its inaugural earnings conference call the same day at 8:30 a.m. Eastern Time to discuss results and answer analyst questions.
Dial-in details: 1-844-425-9470 (U.S.) and 201-298-0878 (international). A live webcast will be available on the PRE conference call page and an audio replay will be posted on the investor relations website at https://ir.prenetics.com/.
Details
News Market Reaction – PRE
On Nov 5, the first trading day after this news, PRE closed 0.66% below the previous close.
Data tracked by StockTitan Argus for the Nov 5 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced it will release financial results for the third quarter 2025 ended September 30, 2025 before market open on Monday, November 10, 2025. The Company will also hold its first ever earnings conference call the same day at 8:30 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.
| Date: | Monday, November 10, 2025 |
| Time: | 8:30 a.m. Eastern Time |
| Dial-in: | 1-844-425-9470 |
| International Dial-in: | 201-298-0878 |
| Webcast | PRE Conference Call |
An audio replay of the webcast will be available on the Company’s investor relations website at https://ir.prenetics.com/.
About Prenetics
Prenetics (NASDAQ: PRE) is a leading health sciences company redefining the future of health and longevity through IM8 — its flagship consumer brand co-founded with David Beckham and championed by World No. 1 and four-time Grand Slam winner Aryna Sabalenka — now the fastest-growing supplement brand globally, reaching
As the first consumer health company to establish a Bitcoin Treasury, Prenetics continues to pioneer at the intersection of health innovation and digital assets — purchasing 1 Bitcoin per day, now totaling 382 BTC as of November 4, 2025.
Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us
Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.